Serveur d'exploration H2N2 - Checkpoint (Ncbi)

Index « Mesh.i » - entrée « Vaccines, Synthetic »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Vaccines, Subunit < Vaccines, Synthetic < Vaccines, Virus-Like Particle  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 12.
Ident.Authors (with country if any)Title
000079 (1992) S B Dillon [États-Unis] ; S G Demuth ; M A Schneider ; C B Weston ; C S Jones ; J F Young ; M. Scott ; P K Bhatnaghar ; S. Locastro ; N. HannaInduction of protective class I MHC-restricted CTL in mice by a recombinant influenza vaccine in aluminium hydroxide adjuvant.
000693 (2011) Kortney M. Gustin [États-Unis] ; Taronna R. Maines ; Jessica A. Belser ; Neal Van Hoeven ; Xuihua Lu ; Libo Dong ; Irina Isakova-Sivak ; Li-Mei Chen ; J Theo M. Voeten ; Jacco G M. Heldens ; Han Van Den Bosch ; Nancy J. Cox ; Terrence M. Tumpey ; Alexander I. Klimov ; Larisa Rudenko ; Ruben O. Donis ; Jacqueline M. KatzComparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets.
000950 (????) L A Stepanova ; A A Kovaleva ; M V Potapchuk ; A V Korotkov ; V V Kupriianov ; E A Blokhina ; R Iu Kotliarov ; L M Tsybalova[Immunogenicity of recombinant proteins including ectodomain of M2 influenza virus A].
000A21 (2014) Irina Isakova-Sivak [États-Unis, Russie] ; Li-Mei Chen [États-Unis] ; Melissa Bourgeois [États-Unis] ; Yumiko Matsuoka [États-Unis] ; J. Theo M. Voeten [Pays-Bas] ; Jacco G. M. Heldens [Pays-Bas] ; Han Van Den Bosch [Pays-Bas] ; Alexander Klimov [États-Unis] ; Larisa Rudenko [Russie] ; Nancy J. Cox [États-Unis] ; Ruben O. Donis [États-Unis]Characterization of Reverse Genetics-Derived Cold-Adapted Master Donor Virus A/Leningrad/134/17/57 (H2N2) and Reassortants with H5N1 Surface Genes in a Mouse Model
000B66 (2015) Liudmila M. Tsybalova [Russie] ; Liudmila A. Stepanova [Russie] ; Victor V. Kuprianov [Russie] ; Elena A. Blokhina [Russie] ; Marina V. Potapchuk [Russie] ; Alexander V. Korotkov [Russie] ; Andrey N. Gorshkov [Russie] ; Marina A. Kasyanenko [Russie] ; Nikolai V. Ravin [Russie] ; Oleg I. Kiselev [Russie]Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e.
000B92 (2015) José Vicente Pérez-Gir N ; Sergio G Mez-Medina ; Anja Lüdtke ; Cesar Munoz-Fontela [Allemagne]Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity.
000E30 (1989) M L Clements [États-Unis] ; S D Sears ; K. Christina ; B R Murphy ; M H SnyderComparison of the virologic and immunologic responses of volunteers to live avian-human influenza A H3N2 reassortant virus vaccines derived from two different avian influenza virus donors.
001038 (1988) R F Betts [États-Unis] ; R G Douglas ; H F Maassab ; D C Deborde ; M L Clements ; B R MurphyAnalysis of virus and host factors in a study of A/Peking/2/79 (H3N2) cold-adapted vaccine recombinant in which vaccine-associated illness occurred in normal volunteers.
001057 (1988) M. Wysocka [États-Unis] ; J R BenninkLimiting dilution analysis of memory cytotoxic T lymphocytes specific for individual influenza virus gene products.
001300 (1994) I N Mbawuike [États-Unis] ; S B Dillion ; S G Demuth ; C S Jones ; T R Cate ; R B CouchInfluenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein.
001322 (1993) L F Fries [États-Unis] ; S B Dillon ; J E Hildreth ; R A Karron ; A W Funkhouser ; C J Friedman ; C S Jones ; V G Culleton ; M L ClementsSafety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers and protective efficacy against wild-type H1N1 virus challenge.
001330 (1996) H. Sagawa [Japon] ; A. Ohshima ; I. Kato ; Y. Okuno ; Y. IsegawaThe immunological activity of a deletion mutant of influenza virus haemagglutinin lacking the globular region.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Vaccines, Synthetic" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Vaccines, Synthetic" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Vaccines, Synthetic
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021